Immunohistochemistry in the evaluation of melanocytic tumors.
A review is given on the classification of melanoma-associated antigens and their relevance as tumor markers in tissue sections and cell preparation. Applications of immunohistochemistry in the diagnosis and prognosis of melanocytic tumors are discussed.
Department of Pathology, University Hospital Nijmegen, Nijmegen, The Netherlands.
D J
DJ
Ruiter
E B
EB
Bröcker
D000911:Antibodies, Monoclonal; D000943:Antigens, Differentiation / Q000032:analysis*; D000951:Antigens, Neoplasm / Q000032:analysis*; D014408:Biomarkers, Tumor / Q000032:analysis*; D006023:Glycoproteins / Q000032:analysis; D006684:HLA-DR Antigens / Q000032:analysis; D006801:Humans; D008545:Melanoma / Q000276:immunology* / Q000473:pathology / Q000556:secondary; D011509:Proteoglycans / Q000032:analysis; D009418:S100 Proteins / Q000032:analysis; D012680:Sensitivity and Specificity
D000911:Antibodies, Monoclonal; D000943:Antigens, Differentiation; D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D006023:Glycoproteins; D006684:HLA-DR Antigens; D011509:Proteoglycans; D009418:S100 Proteins; C069150:melanoma-associated proteoglycan antigen, human